+86-571-8627 3270
Zhejiang Langhua Pharmaceutical Co.,Ltd.
24 YRS
Zhejiang, China
CNY 120 Million
139860 m²
100-500 people
Main Products: Ciprofloxacin / Ciprofloxacin Hydrochloride Hydrate / Enrofloxacin / Levofloxacin Hemihydrate / Canrenone / Spironolactone / Olanzapine / Zidovudine / Empagliflozin / Gsk1349572 Sodium Salt
Zhejiang, China
ABOUT US
Zhejiang Langhua Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating R & D, production and trade. As a subsidiary of Weiya biotechnology holding group, a leading enterprise in the field of innovative drug discovery, Langhua is committed to providing global partners with high-efficiency, flexible and high-quality cdmo one-stop solutions for small molecule drugs, from APIs to preparations, from preclinical to commercial supply, covering the whole life cycle of drugs, At the same time, it provides high-quality small molecule imitation APIs for the global market. It is the main manufacturer of global quinolones, spironolactone, olanzapine, antiviral and other APIs. Ningbo noble Pharmaceutical Co., Ltd., formerly known as the pharmaceutical division of zhongninghua group, has more than 30 years of international market development experience. In 2018, it became a wholly-owned subsidiary of Langhua pharmaceutical, focusing on the operation of pharmaceutical intermediates, APIs, preparations, medical devices and other products, and providing global customers with high-quality pharmaceutical products and services. After more than ten years of development, Langhua has established a perfect quality management system and EHS management system, and has a domestic leading API and preparation R & D technology platform. Deeply involved in the listing process of more than 20 new drugs, the product line covers cancer, AIDS, diabetes, cardiovascular and other fields, and has a good delivery record. Langhua has successively passed the audit and certification of nmpa, FDA, EDQM, PMDA, Anvisa, who and other authoritative institutions, and passed the PSCI audit. It has long provided high-quality products and services for global new drug R & D institutions and multinational pharmaceutical companies, so that patients can buy and afford urgently needed drugs and contribute to human health.
Basic Information
Tax ID
913310827200260813
Country/Region
Zhejiang, China
Year Established
2000
Registered Capital
CNY 120 Million
Business Type
CDMO
Total Employees
100-500 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
It is a major global manufacturer of quinolones, spironolactone, olanzapine, antiviral and other APIs.
PLANT LOCATION
COMPANY ALBUM
办公区域
办公区域
办公区域
生产车间
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >